Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study

BACKGROUND: Myelodysplastic syndromes (MDS) are characterized by ineffective erythropoiesis with dysplastic bone marrow leading to peripheral cytopenia, risk of infection, and progression to acute myelogenous leukemia. Maitake mushroom beta-glucan, a dietary supplement, stimulates hematopoietic prog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Immunother
Main Authors: Wesa, Kathleen M., Cunningham-Rundles, Susanna, Klimek, Virginia M., Vertosick, Emily, Coleton, Marci I., Yeung, K. Simon, Lin, Hong, Nimer, Stephen, Cassileth, Barrie R.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4317517/
https://ncbi.nlm.nih.gov/pubmed/25351719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-014-1628-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados